250 related articles for article (PubMed ID: 16839851)
1. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
Hara M; Iso-O N; Satoh H; Noto H; Togo M; Ishibashi S; Kimura S; Kadowaki T; Hashimoto Y; Tsukamoto K
Metabolism; 2006 Aug; 55(8):1129-34. PubMed ID: 16839851
[TBL] [Abstract][Full Text] [Related]
2. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
[TBL] [Abstract][Full Text] [Related]
5. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
6. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
Tsukamoto K; Maugeais C; Glick JM; Rader DJ
J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
[TBL] [Abstract][Full Text] [Related]
7. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM
J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
Huang Y; Liu XQ; Rall SC; Mahley RW
J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
[TBL] [Abstract][Full Text] [Related]
9. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
Sehayek E; Lewin-Velvert U; Chajek-Shaul T; Eisenberg S
J Clin Invest; 1991 Aug; 88(2):553-60. PubMed ID: 1864965
[TBL] [Abstract][Full Text] [Related]
10. The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice.
Mensenkamp AR; Van Luyn MJ; Havinga R; Teusink B; Waterman IJ; Mann CJ; Elzinga BM; Verkade HJ; Zammit VA; Havekes LM; Shoulders CC; Kuipers F
J Hepatol; 2004 Apr; 40(4):599-606. PubMed ID: 15030975
[TBL] [Abstract][Full Text] [Related]
11. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis.
Dergunov AD; Visvikis-Siest S; Siest G
Vascul Pharmacol; 2008; 48(2-3):70-5. PubMed ID: 18221919
[TBL] [Abstract][Full Text] [Related]
12. Use of transgenic mice to study the role of apolipoprotein E in lipid metabolism and atherosclerosis.
Willems Van Dijk K; Hofker MH; Havekes LM
Int J Tissue React; 2000; 22(2-3):49-58. PubMed ID: 10937354
[TBL] [Abstract][Full Text] [Related]
13. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
[TBL] [Abstract][Full Text] [Related]
14. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
Kuipers F; Jong MC; Lin Y; Eck M; Havinga R; Bloks V; Verkade HJ; Hofker MH; Moshage H; Berkel TJ; Vonk RJ; Havekes LM
J Clin Invest; 1997 Dec; 100(11):2915-22. PubMed ID: 9389759
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
Huang Y; Liu XQ; Rall SC; Taylor JM; von Eckardstein A; Assmann G; Mahley RW
J Biol Chem; 1998 Oct; 273(41):26388-93. PubMed ID: 9756870
[TBL] [Abstract][Full Text] [Related]
16. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara T; Ramakrishnan R; Steiner G; Shachter NS
J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
[TBL] [Abstract][Full Text] [Related]
18. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
Jong MC; Dahlmans VE; Hofker MH; Havekes LM
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
[TBL] [Abstract][Full Text] [Related]
19. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
Liu G; Excoffon KJ; Wilson JE; McManus BM; Miao L; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME
Clin Invest Med; 1998; 21(4-5):172-85. PubMed ID: 9800066
[TBL] [Abstract][Full Text] [Related]
20. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
